Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

One-carbon Therapeutics has secured SEK 153 million (€13.9 million) in [...]

Scancell has reported updated results from its Phase 2 SCOPE [...]

Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]